AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans
DELFT, The Netherlands, June 30, 2026 (GLOBE NEWSWIRE) -- AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on native Outer Membrane Vesicles (nOMVs), today announces the publication of first-in-human …